Gliduocure Tablet 10/100 mg
Dapagliflozin Propanediol Hydrate 12.3mg · Sitagliptin Phosphate Hydrate 128.5mg
Tablet · Prescription medication · Combination
Seongyi Bio Pharmaceutical Co., Ltd.
MFDS item code 202200215 · Approved 2022.01.12
Improvement of blood glucose control in patients with type 2 diabetes mellitus
This medication is prescribed in conjunction with dietary changes and exercise programs to assist in blood glucose control for patients with type 2 diabetes using sitagliptin and dapagliflozin together. It is used to effectively manage blood glucose levels and improve symptoms of diabetes.
This medicine may be administered as 1 tablet once daily, with or without food, to patients receiving sitagliptin 100 mg and dapagliflozin 10 mg. The tablet should be swallowed whole. Patients with renal impairment - No dose adjustment is necessary when the estimated glomerular filtration rate[estimated glomerular filtration rate(eGFR)] is 45 mL/min/1.73m2 or higher. - Do not administer this medicine when the estimated glomerular filtration rate(eGFR) is less than 45 mL/min/1.73 m2. Patients with hepatic impairment No dose adjustment is necessary for patients with mild or moderate hepatic impairment. Use of this medicine is not recommended in patients with severe hepatic impairment.
This medication contains sitagliptin and dapagliflozin and is used for the treatment of diabetes. Firstly, sitagliptin may rarely cause serious allergic reactions such as anaphylaxis, angioedema, or skin exfoliative diseases, so if any abnormal symptoms occur within 3 months after administration, it should be discontinued immediately. Additionally, sitagliptin may induce acute pancreatitis, thus if symptoms like abdominal pain or vomiting occur during treatment, it is essential to consult medical personnel immediately. This medication should not be administered to patients with type 1 diabetes, diabetic ketoacidosis, or those undergoing dialysis. Dapagliflozin poses a risk of volume depletion and renal dysfunction, thus patients with impaired kidney function, elderly patients, or those on diuretics should evaluate their fluid status and renal function adequately before administration and be monitored regularly during treatment. This medication may lead to metabolic abnormalities, including severe pancreatitis and diabetic ketoacidosis, so if such symptoms are suspected, immediate discontinuation and treatment should be sought. Furthermore, dapagliflozin may increase the risk of genital and urinary tract infections, so appropriate treatment is necessary if infection symptoms develop. Elderly patients are at higher risk of decreased kidney function, so dose adjustment and renal function tests are recommended. Pregnant or breastfeeding women are advised to avoid using this medication, and it should be discontinued immediately if pregnancy is confirmed. While taking this medication, there is a risk of hypoglycemia, especially when used in conjunction with insulin or sulfonylureas, thus caution is necessary for hypoglycemic symptoms, and dosage adjustments may be required. In cases of overdose, appropriate treatment should be sought according to the symptoms, and while some drug components may be removed by dialysis, specific treatment methods should be discussed with medical personnel. Lastly, this medication has not established safety and efficacy in children, so it should not be used in patients under 18 years of age. There is a risk of hypoglycemia when driving or operating machinery during the use of this medication, so caution is warranted.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to protect against air and moisture and should be kept at room temperature, ideally between 1 to 30 degrees Celsius. Avoid storing in warm or excessively cold places and keep it in a cool place away from direct sunlight.
Bright yellow, rectangular film-coated tablet
Box - 28 tablets/box [(7 tablets/PTP (Alu-Alu) x 4)]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Dapagliflozin Propanediol Hydrate 12.3mg · Sitagliptin Phosphate Hydrate 128.5mg
Tablet · Prescription medication · Combination
Seongyi Bio Pharmaceutical Co., Ltd.
CombinationDapagliflozin Propanediol Hydrate 12.3mg · Sitagliptin Phosphate Hydrate 128.5mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
CombinationDapagliflozin Propanediol Hydrate 12.3mg · Sitagliptin Phosphate Hydrate 128.5mg
Tablet · Prescription medication · Combination
Daewoo Pharmaceutical Co., Ltd.
CombinationDapagliflozin Propanediol Hydrate 12.3mg · Sitagliptin Phosphate Hydrate 128.5mg
Tablet · Prescription medication · Combination
International Pharmaceutical Co., Ltd.
CombinationDapagliflozin Propanediol Hydrate 12.3mg · Sitagliptin Phosphate Hydrate 128.5mg
Tablet · Prescription medication · Combination
Shinpoong Pharmaceutical Co., Ltd.
CombinationDapagliflozin Propanediol Hydrate 12.3mg · Sitagliptin Phosphate Hydrate 128.5mg
Tablet · Prescription medication · Combination
IYON Pharmaceutical Co., Ltd.
CombinationDapagliflozin Propanediol Hydrate 12.3mg · Sitagliptin Phosphate Hydrate 128.5mg
Tablet · Prescription medication · Combination
Kujoo Pharmaceutical Co., Ltd.
Dapagliflozin Propanediol Hydrate 12.3mg · Sitagliptin Phosphate Hydrate 128.5mg
Tablet · Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.